Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Genes (Basel) ; 13(12)2022 11 26.
Artigo em Inglês | MEDLINE | ID: mdl-36553485

RESUMO

Neurological phenotypes such as intellectual disability occur in almost half of patients with neurofibromatosis 1 (NF1). Current genotype-phenotype studies have failed to reveal the mechanism underlying this clinical variability. Despite the presence of pathogenic variants of NF1, modifier genes likely determine the occurrence and severity of neurological phenotypes. Exome sequencing data were used to identify genetic variants in 13 NF1 patients and 457 healthy controls, and this information was used to identify candidate modifier genes underlying neurological phenotypes based on an optimal sequence kernel association test. Thirty-six genes were identified as significant modifying factors in patients with neurological phenotypes and all are highly expressed in the nervous system. A review of the literature confirmed that 19 genes including CUL7, DPH1, and BCO1 are clearly associated with the alteration of neurological functioning and development. Our study revealed the enrichment of rare variants of 19 genes closely related to neurological development and functioning in NF1 patients with neurological phenotypes, indicating possible modifier genes and variants affecting neurodevelopment. Further studies on rare genetic variants of candidate modifier genes may help explain the clinical heterogeneity of NF1.


Assuntos
Neurofibromatose 1 , Humanos , Neurofibromatose 1/complicações , Neurofibromatose 1/genética , Neurofibromatose 1/patologia , Genes Modificadores , Fenótipo , Exoma , Sequenciamento do Exoma
2.
PLoS Biol ; 19(4): e3001190, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33844686

RESUMO

Chemical insecticides have been heavily employed as the most effective measure for control of agricultural and medical pests, but evolution of resistance by pests threatens the sustainability of this approach. Resistance-conferring mutations sometimes impose fitness costs, which may drive subsequent evolution of compensatory modifier mutations alleviating the costs of resistance. However, how modifier mutations evolve and function to overcome the fitness cost of resistance still remains unknown. Here we show that overexpression of P450s not only confers imidacloprid resistance in the brown planthopper, Nilaparvata lugens, the most voracious pest of rice, but also leads to elevated production of reactive oxygen species (ROS) through metabolism of imidacloprid and host plant compounds. The inevitable production of ROS incurs a fitness cost to the pest, which drives the increase or fixation of the compensatory modifier allele T65549 within the promoter region of N. lugens peroxiredoxin (NlPrx) in the pest populations. T65549 allele in turn upregulates the expression of NlPrx and thus increases resistant individuals' ability to clear the cost-incurring ROS of any source. The frequent involvement of P450s in insecticide resistance and their capacity to produce ROS while metabolizing their substrates suggest that peroxiredoxin or other ROS-scavenging genes may be among the common modifier genes for alleviating the fitness cost of insecticide resistance.


Assuntos
Hemípteros/efeitos dos fármacos , Resistência a Inseticidas/efeitos dos fármacos , Neonicotinoides/farmacologia , Nitrocompostos/farmacologia , Oryza/parasitologia , Peroxirredoxinas/fisiologia , Adaptação Biológica/efeitos dos fármacos , Adaptação Biológica/genética , Alelos , Animais , Mapeamento Cromossômico , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Genes de Insetos/efeitos dos fármacos , Genes Modificadores/efeitos dos fármacos , Genes Modificadores/fisiologia , Estudos de Associação Genética , Aptidão Genética/efeitos dos fármacos , Hemípteros/fisiologia , Resistência a Inseticidas/genética , Inseticidas/farmacologia , Oryza/efeitos dos fármacos , Peroxirredoxinas/genética , Espécies Reativas de Oxigênio/metabolismo , Testes de Toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA